Image-guided nanomedicine for cancer

被引:20
作者
Choi J.H. [1 ]
Lee Y.J. [2 ]
Kim D. [1 ]
机构
[1] Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, Reynolds Medical Building, Suite 159, Mail Stop 1114, College Station, 77843-1114, TX
[2] Nutrition and Food Science Department, Texas A&M University, 2476 TAMU, College Station, 77843-2476, TX
关键词
Cancer; Inorganic nanoparticles; Organic nanoparticles; Theranostic;
D O I
10.1007/s40005-016-0297-1
中图分类号
学科分类号
摘要
Since current treatment options applicable to cancers are still confined to chemotherapeutics followed by surgical debulking, cancer disease is a second leading cause of death because of chemotherapeutics of non-specific biodistribution. Image-guided drug delivery system (IGDDS) is a real-time noninvasive imaging assessment of therapeutic response that has the strong potential to control or suppress cancer because imaging property offer the quantification of nanomedicine at the intended disease site, thus the potential assurance of adequate treatment and elimination of undesirable delay leading to poor clinical outcomes. Also, combining pH-sensitive advantages of nanoparticle with theranostic property will have high chance to overcome cancer. There have been intensive researches to develop innovative IGDDS by using nanoparticles including organic or inorganic theranostic (therapy + diagnostic) systems including liposomes, polymeric micelles, dendrimers, carbon nanotubes, gold nanoparticles, iron oxide nanoparticles, quantum dots, and silica nanoparticles. In this review, we will introduce various examples of each system and will discuss their theranostic applications. © 2016, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码:51 / 64
页数:13
相关论文
共 102 条
[41]  
Kim D., Lee E.S., Park K., Et al., Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor, Pharm Res, 25, pp. 2074-2082, (2008)
[42]  
Kim J., Piao Y., Hyeon T., Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy, Chem Soc Rev, 38, pp. 372-390, (2009)
[43]  
Kim H., Kim S., Park C., Et al., Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers, Adv Mater, 22, pp. 4280-4283, (2010)
[44]  
Krause W., Liver-specific X-ray contrast agents, Contrast agents II: optical, ultrasound, X-Ray and radiopharmaceutical imaging, pp. 173-200, (2002)
[45]  
Langereis S., Hijnen N., Strijkers G., Et al., Research Spotlight: Multifunctional liposomes for MRI and image-guided drug delivery, Ther Deliv, 5, pp. 21-24, (2013)
[46]  
Lee C.C., MacKay J.A., Frechet J.M.J., Et al., Designing dendrimers for biological applications, Nat Biotech, 23, pp. 1517-1526, (2005)
[47]  
Lee E.S., Gao Z., Kim D., Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance, J Control Rel, 129, pp. 228-236, (2008)
[48]  
Lee S., Cha E.-J., Park K., A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination, Angew Chem, 120, pp. 2846-2849, (2008)
[49]  
Lee H.-Y., Li Z., Chen K., PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)–conjugated radiolabeled iron oxide nanoparticles, J Nucl Med, 49, pp. 1371-1379, (2008)
[50]  
Lee J.E., Lee N., Kim H., Et al., Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery, J Am Chem Soc, 132, pp. 552-557, (2010)